Conexant (CNXT) Down On Share Offering
Conexant (CNXT) it intends to offer to sell, subject to market and other conditions, 7 million shares of its common stock in an underwritten public offering. The stock down 8%.
Douglas A. McIntyre
Hercules (HERO) Pounded On Poor Results
Hercules OffShore (HERO) is trading off by 11% to $5.58 against a 52-week high of $18.09.
Hercules Offshore forecast third-quarter revenue of $155 million to $160 million, below what analysts have been expecting. The company was forecsast to do over $165.
Hercules also said it would offer up to 17.5 million shares of stock.
Douglas A. McIntyre
Helicos BioSciences (HLCS) Lifts In Pre-Market
Helicos BioSciences (HLCS) is up nearly 15% to $2.70 on news of the the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS)™ technology was used to directly sequence individual molecules of RNA. The paper appeared yesterday in the on-line edition of Nature and will appear in an upcoming 2009 print [...]
Vical (VICL) Surges On Cancer Study
Vical (VICL) is up 16% to $4.86 on news about the the presentation of encouraging results from animal studies of a peptide-based cancer vaccine formulated with the company’s Vaxfectin(R) adjuvant. Sean M. Sullivan, Ph.D., Vical’s Executive Director of Pharmaceutical Sciences, is presenting data at the IIRUSA Vaccines Development Forum (Boston – September 23-25) demonstrating the [...]
VS Investor RSS Feed